Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
SARS-CoV-2 detection with CRISPR diagnostics
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
SARS-CoV-2 detection with CRISPR diagnostics
Creator
Li, Wei
Liang, Chen
Zhou, Qi
Wang, Liu
Chen, Yangcan
Dai, Moyu
Fang, Sen
Feng, Guihai
Gao, Qingqin
Gu, Qi
Guo, Lu
Jiang, Haiping
Mao, Yihuan
Qu, Bin
Sun, Xuehan
Wang, Ruiqi
Wang, Xinge
Source
BioRxiv
abstract
The novel coronavirus (CoV) disease termed COVID-19 (Coronavirus Disease-19) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) is causing a massive pandemic worldwide, threatening public health systems across the globe. During this ongoing COVID-19 outbreak, nucleic acid detection has played an important role in early diagnosis. Here we report a SARS-CoV-2 detection protocol using a CRISPR-based CRISPR diagnostic platform - CDetection (Cas12b-mediated DNA detection). By combining sample treatment protocols and nucleic acid amplification methods with CDetection, we have established an integrated viral nucleic acid detection platform - CASdetec (CRISPR-assisted detection). The detection limit of CASdetec for SARS-CoV-2 pseudovirus is 1 × 104 copies/mL, with no cross reactivity observed. Our assay design and optimization process can provide guidance for future CRISPR-based nucleic acid detection assay development and optimization.
has issue date
2020-04-11
(
xsd:dateTime
)
bibo:doi
10.1101/2020.04.10.023358
has license
biorxiv
sha1sum (hex)
cdf2bb810fd33f983b42c461eabae8e4472ec434
schema:url
https://doi.org/10.1101/2020.04.10.023358
resource representing a document's title
SARS-CoV-2 detection with CRISPR diagnostics
schema:publication
bioRxiv
resource representing a document's body
covid:cdf2bb810fd33f983b42c461eabae8e4472ec434#body_text
is
schema:about
of
named entity 'disease'
named entity 'CRISPR'
named entity 'NOVEL CORONAVIRUS'
named entity 'World Health Organization'
named entity 'fluorescence'
named entity 'POCT'
named entity 'signal-to-background ratio'
named entity 'pseudovirus'
named entity 'detection limit'
named entity 'COVID-19 outbreak'
named entity 'SARS-CoV'
named entity 'CRISPR'
named entity '10 nM'
named entity 'nucleic acid detection'
named entity 'SARS-CoV-2'
named entity 'fluorescence'
named entity 'CRISPR'
named entity 'lysis buffer'
named entity 'nucleic acid detection'
named entity 'nucleic acid amplification'
named entity 'primers'
named entity 'coronaviruses'
named entity 'nucleic acid detection'
named entity 'coronavirus'
named entity 'RNA'
named entity 'detection limit'
named entity 'fluorescence'
named entity 'CRISPR'
named entity 'microliter'
named entity 'fluorescence'
named entity 'lentivirus'
named entity 'endemic'
named entity 'CRISPR'
named entity 'SARS-CoV-2'
named entity 'assay'
named entity 'CRISPR'
named entity 'coronavirus'
named entity 'detection limit'
named entity 'CRISPR'
named entity 'lysis buffer'
named entity 'assay'
named entity 'public health'
named entity 'COVID-19 outbreak'
named entity 'pseudovirus'
named entity 'RdRp'
named entity 'point-of-care testing'
named entity 'MERS-CoV'
named entity 'SARS'
named entity 'SARS-CoV'
named entity 'nucleotide'
named entity 'cross-reactivity'
named entity 'primers'
named entity 'RNA'
named entity 'Severe Acute Respiratory Syndrome Coronavirus'
named entity 'CRISPR'
named entity 'SARS-CoV'
named entity 'lysis buffer'
named entity 'assay'
named entity 'nucleic acid amplification'
named entity 'SARS-CoV-2'
named entity 'sensitivity and specificity'
named entity 'quenchers'
named entity 'SARS-CoV-2'
named entity 'Institute of Zoology'
named entity 'CRISPR'
named entity 'coronaviruses'
named entity 'WHO'
named entity 'fluorescence'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 2
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software